Valganciclovir 50mg/mL Oral Suspension

Liquid oral suspension at 50mg/mL valganciclovir hydrochloride for pediatric or swallowing-impaired patients treating CMV disease. HTS 3004.90.92.05 applies as it's a measured dose antiviral containing valganciclovir salt for retail therapeutic use.

Import Duty Rates by Country of Origin

Origin CountryMFN RateCh.99 SurchargesTotal Effective Rate
🇨🇳ChinaFreeFree
🇲🇽MexicoFreeFree
🇨🇦CanadaFreeFree
🇩🇪GermanyFreeFree
🇯🇵JapanFreeFree

Alternative Classifications

This product could be classified differently depending on its characteristics or intended use.

3004.90Same rate: Free

If other anti-infective liquid preparations

Liquid medicaments not specifically antivirals or without named actives classified differently.

3824.99Higher: 15% vs Free

If imported as unfinished concentrate

Concentrated preparations not put up in retail measured doses fall to Chapter 38.

Not sure which classification is right?

Our AI classifier can analyze your specific product and recommend the correct HTS code with confidence.

Import Tips & Compliance

Provide validated stability data for liquid formulation under varying storage conditions

Ensure child-resistant closures meet CPSC standards for liquid medicaments

Test for microbial contamination specific to oral suspensions during import inspection

Related Products under HTS 3004.90.92.05

Valganciclovir Hydrochloride 450mg Tablets

These are oral tablets containing 450mg of valganciclovir hydrochloride, an antiviral medication used to treat cytomegalovirus (CMV) infections in immunocompromised patients. Classified under HTS 3004.90.92.05 as an anti-infective antiviral medicament put up in measured doses for retail sale, consisting of valganciclovir salt in unmixed form.

Valcyte 450mg Film-Coated Tablets

Brand name Valcyte tablets with 450mg valganciclovir hydrochloride, film-coated for CMV retinitis and prevention in transplant patients. Falls under HTS 3004.90.92.05 due to specific valganciclopivir salt content in measured retail doses as an antiviral anti-infective.

Peramivir 200mg Intravenous Injection

Single-dose 200mg vial of peramivir for IV infusion treating acute influenza in hospitalized patients. Classified in HTS 3004.90.92.05 as antiviral anti-infective in measured sterile doses containing peramivir for therapeutic use.

Rapivab 600mg/60mL IV Solution

Branded Rapivab peramivir injection 600mg in 60mL ready-to-use IV bags for influenza treatment. HTS 3004.90.92.05 due to peramivir content in measured prophylactic/therapeutic doses for retail sale.

Valganciclovir Hydrochloride 900mg Extended-Release Tablets

High-dose 900mg extended-release tablets of valganciclovir HCl for once-daily CMV prophylaxis in transplant recipients. Falls under HTS 3004.90.92.05 as specified antiviral in measured retail doses despite modified release profile.

Pediatric Valganciclovir 250mg Tablets

Smaller 250mg valganciclovir tablets scored for pediatric dosing of CMV infections. HTS 3004.90.92.05 classification as measured antiviral doses containing valganciclovir salt for therapeutic retail sale.